查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2024125

低溫運輸配送市場預測至2034年－按溫度類型、組件、配送方式、服務類型、組織規模、最終用戶和地區分類的全球分析

Cold-Chain Delivery Market Forecasts to 2034 - Global Analysis By Temperature Type (Chilled (< 8&deg;C), Frozen (< -18&deg;C), and Deep Cold (< -60&deg;C)), Component, Delivery Mode, Service Type, Organization Size, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球低溫運輸配送市場規模將達到 1,126 億美元，並在預測期內以 16.6% 的複合年成長率成長，到 2034 年將達到 3,865 億美元。

低溫運輸配送是指旨在維持食品、藥品和化學品等生鮮產品品質的溫控供應鏈解決方案。該系統整合了冷藏設施、保溫包裝、即時監控系統和物流服務，以維持從冷藏到超低溫的特定溫度範圍。低溫運輸配送旨在確保產品安全、符合法規要求並減少變質，使各行業能夠將對溫度敏感的產品運送到世界各地。該系統顯著有助於減少廢棄物，透過疫苗分發改善醫療保健效果，並支援各行各業的即時供應模式。

對溫度敏感型藥物的需求不斷成長

生技藥品需要嚴格控制在2°C至8°C之間的溫度，而先進的基因療法則需要低於-60°C的低溫環境。 mRNA疫苗和胰島素類似物的全球推廣應用進一步凸顯了基礎設施的不足和改善機會。製藥公司正在投資即時追蹤系統和物聯網冷藏箱，以確保藥物療效。監管機構正在執行更嚴格的藥品良好分銷規範（GDP），並要求物流供應商提高運能。隨著生物製藥研發管線的不斷擴展，低溫運輸配送對於已開發市場和新興市場的病人安全和市場進入都至關重要。

高昂的營運成本和基礎設施成本

從生產到最後一公里配送，全程保持不間斷的溫度控制需要對冷凍設備、保溫貨櫃和溫度記錄器進行大量資本投入。冷藏設施和車輛的能源成本波動較大，對物流業者的利潤率帶來壓力。在發展中地區，電力供應不足和道路網路不發達加劇了溫度偏差和產品損失的風險。中小企業難以負擔先進監控系統和不間斷供電解決方案的部署費用。員工操作訓練也是一項持續的支出。這些財務障礙限制了市場准入，延緩了先進低溫運輸技術的應用，尤其是在價格敏感型領域。

引進物聯網和區塊鏈技術進行即時監控

物聯網 (IoT) 感測器與區塊鏈技術的融合正在革新低溫運輸的可視性和可追溯性。溫度、濕度和衝擊等即時數據如今可以透過無線方式傳輸，從而實現運輸過程中的主動干預。區塊鏈為每次交接創建防篡改記錄，簡化監管審計並減少責任糾紛。物流業者正在利用預測分析來最佳化路線並降低能耗。大型製藥企業強制要求對所有高價值貨物進行數位化溫度監控。隨著感測器成本的下降和 5G 的普及，即使是小規模低溫運輸營運商也能部署智慧追蹤解決方案。

易受極端天氣事件影響

氣候變遷導致熱浪、洪水和風暴的發生頻率增加，直接威脅低溫運輸的可靠性。極端高溫會加速冷凍系統的故障，洪水則會破壞倉庫和陸上運輸網路。惡劣天氣造成的停電會擾亂冷藏倉庫的運行，可能導致價值數百萬美元的疫苗和生鮮食品被銷毀。對溫度敏感貨物的保險費不斷上漲，索賠案件也在增加。如果沒有冗餘系統和自適應路線規劃，企業將面臨庫存減損和聲譽受損的風險。區域基礎設施的不平衡進一步加劇了這些風險，尤其是在低溫運輸密度本就較低的熱帶和沿海地區。

新冠疫情的影響

疫情擾亂了傳統的食品供應鏈，同時也對疫苗低溫運輸物流提出了前所未有的需求。封鎖措施延緩了設備製造以及冷媒和乾冰的跨境運輸。然而，新冠疫情加速了對超低溫冷凍庫和末端配送無人機的投資。監管機構發布了關於溫度偏差的緊急指南，在危機期間提供了一定的柔軟性。疫情過後，世界各國政府優先考慮透過公私合營加強低溫運輸韌性。數位化溫度監控已成為標準做法，冷藏設施的近岸外包也蓬勃發展。這場危機永久提高了整個低溫運輸配送生態系統對品質和營運彈性的期望。

在預測期內，醫藥和生技領域預計將佔據最大的市場佔有率。

在預測期內，醫藥和生技領域預計將佔據最大的市場佔有率。這主要得益於生技藥品、疫苗和細胞療法的快速成長。這些產品對溫度要求嚴格，部分產品甚至需要在-60 度C以下的低溫條件下保存。個人化醫療和生物相似藥的推廣應用進一步增加了運輸量。醫院和藥局正在實施專用低溫運輸包裝和即時監控，以符合藥品生產品質管理規範（GDP）標準。在新興市場，政府正透過免疫接種計畫擴大疫苗低溫運輸基礎設施。

在預測期內，超低溫（低於 -60 度C）細分市場預計將呈現最高的複合年成長率。

在預測期內，由於mRNA疫苗、CAR-T細胞療法和基因編輯產品的興起，超低溫（低於-60 度C）運輸領域預計將呈現最高的成長率。這些先進的生技藥品需要使用乾冰或液態氮的低溫環境，這推動了對專用冷凍庫和杜瓦瓶的需求。腫瘤學和個人化細胞療法的臨床試驗正在增加全球對超低溫運輸的需求。物流業者正在開發輕型真空隔熱容器以延長保存期限。新的發展趨勢包括電動低溫冷藏貨櫃和雲端基礎溫度映射。

市佔率最大的地區

在預測期內，北美地區預計將保持最大的市場佔有率，這主要得益於基礎設施現代化和藥品進口量的成長。阿拉伯聯合大公國和沙烏地阿拉伯正在建造溫控物流區，以期成為區域低溫運輸樞紐。氣候變遷導致氣溫上升，使得強大的冷凍系統對食品安全至關重要。各國政府正放寬外國直接投資（FDI）法規，以吸引對低溫運輸的投資。此外，該地區在偏遠地區使用太陽能冷藏庫和物聯網追蹤系統方面也取得了快速進展。

複合年成長率最高的地區

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於快速的都市化、不斷擴大的製藥業以及日益成長的食品出口。中國、印度和越南正在大力投資冷庫和冷藏運輸網。政府措施正在支持從農場到餐桌的新鮮農產品和乳製品低溫運輸。該地區也是疫苗生產中心，需要可靠的疫苗配送系統將疫苗送達偏遠地區。

免費客製化服務

所有購買此報告的客戶均可享受以下免費自訂選項之一。

  • 企業概況
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 我們根據客戶要求提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 透過產品系列、地理覆蓋範圍和策略聯盟對標主要企業。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 成長機會和重點投資領域
  • 工業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章：全球低溫運輸配送市場：依溫度類型分類

  • 冷藏（低於 8 度C）
  • 冰凍（低於-18 度C）
  • 超低溫（低於-60 度C）

第6章：全球低溫運輸經銷市場：依組件分類

  • 解決方案
    • 冷凍設備
    • 包裝和隔熱材料
    • 監控系統
  • 服務
    • 交通運輸服務
    • 倉儲/倉庫
    • 安裝/維護
    • 低溫運輸諮詢

第7章 全球低溫運輸配送市場：以配送方式分類

  • 道路網路
  • 鐵路
  • 航空郵件
  • 海洋和水道
  • 多式聯運

第8章：全球低溫運輸配送市場：依服務類型分類

  • 專用低溫運輸
  • 共用低溫運輸
  • 混合解決方案

第9章 全球低溫運輸分銷市場：依組織規模分類

  • 大公司
  • 中小企業

第10章：全球低溫運輸配送市場：依最終用戶分類

  • 飲食
    • 水果和蔬菜
    • 乳製品和冷凍甜點
    • 肉類、家禽和水產品
    • 麵包糖果甜點
    • 飲料
  • 製藥和生物技術
    • 疫苗
    • 生技藥品及血液製品
  • 化學品/特殊材料
  • 化妝品和個人護理
  • 其他

第11章 全球低溫運輸分銷市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 其他
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲地區

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章：產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟、合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Americold Logistics
  • Lineage Logistics
  • DHL International GmbH
  • United Parcel Service（UPS）
  • Maersk
  • CEVA Logistics
  • Kuehne+Nagel International
  • CH Robinson Worldwide
  • FedEx Corporation
  • Nippon Express
  • DB Schenker
  • XPO Logistics
  • AGRO Merchants Group
  • NewCold Advanced Cold Logistics
  • VersaCold Logistics Services
Product Code: SMRC35336

According to Stratistics MRC, the Global Cold-Chain Delivery Market is accounted for $112.6 billion in 2026 and is expected to reach $386.5 billion by 2034 growing at a CAGR of 16.6% during the forecast period. Cold-chain delivery encompasses temperature-controlled supply chain solutions designed to preserve the integrity of perishable goods, including food, pharmaceuticals, and chemicals. It integrates refrigeration equipment, insulated packaging, real-time monitoring systems, and logistics services to maintain specific temperature ranges from chilled to deep cold. Built to ensure product safety, regulatory compliance, and reduced spoilage, cold-chain delivery enables industries to transport sensitive products globally. This system contributes significantly to reducing waste, improving healthcare outcomes through vaccine distribution, and supporting just-in-time supply models across multiple sectors.

Market Dynamics:

Driver:

Growing demand for temperature-sensitive pharmaceuticals

Biologics require strict temperature control between 2°C and 8°C, while advanced gene therapies demand cryogenic conditions below -60°C. The global rollout of mRNA vaccines and insulin analogues has further highlighted infrastructure gaps and opportunities. Pharmaceutical companies are investing in real-time tracking and IoT-enabled cold boxes to ensure drug efficacy. Regulatory agencies are enforcing stricter Good Distribution Practices (GDP), pushing logistics providers to upgrade capabilities. As biopharmaceutical pipelines grow, cold-chain delivery becomes critical for patient safety and market access across developed and emerging economies.

Restraint:

High operational and infrastructure costs

Maintaining uninterrupted temperature control from manufacturing to last-mile delivery requires significant capital investment in refrigeration units, insulated containers, and temperature loggers. Energy costs for cold storage facilities and refrigerated vehicles remain volatile, compressing profit margins for logistics providers. In developing regions, inadequate power supply and poor road networks increase the risk of temperature excursions and product losses. Small and medium enterprises struggle to afford advanced monitoring systems and backup power solutions. Training personnel on proper handling procedures adds recurring expenses. These financial barriers limit market entry and slow the adoption of best-in-class cold-chain technologies, particularly in price-sensitive segments.

Opportunity:

Adoption of IoT and blockchain for real-time monitoring

Integrating Internet of Things (IoT) sensors and blockchain technology is transforming cold-chain visibility and traceability. Real-time temperature, humidity, and shock data can now be transmitted wirelessly, enabling proactive intervention during transit. Blockchain creates immutable records of each handoff, simplifying regulatory audits and reducing liability disputes. Logistics providers are leveraging predictive analytics to optimize routing and reduce energy consumption. Pharmaceutical giants are mandating digital temperature monitoring for all high-value shipments. As sensor costs decline and 5G coverage expands, even small-scale cold-chain operators can deploy smart tracking solutions.

Threat:

Vulnerability to extreme weather events

Climate change is increasing the frequency of heatwaves, floods, and storms, directly threatening cold-chain reliability. Extreme heat accelerates refrigeration system failures, while floods damage warehouses and ground transport networks. Power outages during severe weather disrupt cold storage operations, potentially destroying millions of dollars worth of vaccines or fresh produce. Insurance premiums for temperature-sensitive cargo are rising, and liability claims are becoming more common. Without redundant systems and adaptive routing, companies face inventory write-offs and reputational damage. Regional infrastructure disparities exacerbate these risks, particularly in tropical and coastal zones where cold-chain density is already low.

Covid-19 Impact

The pandemic created unprecedented demand for vaccine cold-chain logistics while disrupting conventional food supply chains. Lockdowns delayed equipment manufacturing and cross-border shipments of refrigerants and dry ice. However, COVID-19 accelerated investments in ultra-low-temperature freezers and last-mile delivery drones. Regulatory bodies issued emergency guidelines for temperature excursions, allowing some flexibility during crises. Post-pandemic, governments have prioritized cold-chain resilience through public-private partnerships. Digital temperature monitoring became standard practice, and nearshoring of cold storage facilities gained traction. The crisis permanently raised quality expectations and operational agility across the cold-chain delivery ecosystem.

The pharmaceuticals & biotechnology segment is expected to be the largest during the forecast period

The pharmaceuticals & biotechnology segment is expected to account for the largest market share during the forecast period, driven by the exponential growth of biologic drugs, vaccines, and cell therapies. These products mandate strict temperature ranges, with some requiring cryogenic conditions below -60°C. The expansion of personalized medicine and biosimilars is further increasing shipment volumes. Hospitals and pharmacies are adopting specialized cold-chain packaging and real-time monitoring to comply with GDP standards. Emerging markets are scaling up vaccine cold-chain infrastructure through government immunization programs.

The deep cold (< -60°C) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the deep cold (below -60°C) temperature segment is predicted to witness the highest growth rate, fueled by the rise of mRNA vaccines, CAR-T cell therapies, and gene editing products. These advanced biologics require cryogenic conditions using dry ice or liquid nitrogen, driving demand for specialized freezers and dewars. Oncology clinical trials and personalized cell therapies are increasing deep-cold shipments globally. Logistics providers are developing lightweight, vacuum-insulated containers for extended hold times. Emerging trends include electric cryogenic reefers and cloud-based temperature mapping.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by infrastructure modernization and growing pharmaceutical imports. The UAE and Saudi Arabia are developing temperature-controlled logistics zones to become regional cold-chain hubs. Rising temperatures due to climate change make robust cooling systems essential for food safety. Governments are easing FDI regulations to attract cold-chain investments. The region is also witnessing rapid adoption of solar-powered refrigerators and IoT tracking for remote areas.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapid urbanization, expanding pharmaceutical manufacturing, and growing food export volumes. China, India, and Vietnam are investing heavily in cold-storage warehouses and refrigerated transport networks. Government initiatives support farm-to-fork cold chains for perishable produce and dairy. The region is also a hub for vaccine production, requiring reliable distribution to remote areas.

Key players in the market

Some of the key players in Cold-Chain Delivery Market include Americold Logistics, Lineage Logistics, DHL International GmbH, United Parcel Service, Maersk, CEVA Logistics, Kuehne + Nagel International, C.H. Robinson Worldwide, FedEx Corporation, Nippon Express, DB Schenker, XPO Logistics, AGRO Merchants Group, NewCold Advanced Cold Logistics, and VersaCold Logistics Services.

Key Developments:

In December 2025, Americold Realty Trust, a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition, and development of temperature-controlled warehouses, today announced a new partnership with On the Run ("OTR"), one of Australia's most recognized P&C brands. Americold will provide storage and distribution services to support OTR's supply chain in Adelaide and its rapid national expansion.

In March 2025, Lineage Logistics announced the acquisition of a network of cold-storage facilities in Southeast Asia, expanding its presence in emerging markets. The move strengthens cross-border temperature-controlled freight between Vietnam, Thailand, and China.

Temperature Types Covered:

  • Chilled (< 8°C)
  • Frozen (< -18°C)
  • Deep Cold (< -60°C)

Components Covered:

  • Solutions
  • Services

Delivery Modes Covered:

  • Roadways
  • Railways
  • Airways
  • Sea/Waterways
  • Multimodal Logistics

Service Types Covered:

  • Dedicated Cold-Chain
  • Shared Cold-Chain
  • Hybrid Solutions

Organization Sizes Covered:

  • Large Enterprises
  • Small & Medium Enterprises (SMEs)

End Users Covered:

  • Food & Beverages
  • Pharmaceuticals & Biotechnology
  • Chemicals & Specialty Materials
  • Cosmetics & Personal Care
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Cold-Chain Delivery Market, By Temperature Type

  • 5.1 Chilled (< 8°C)
  • 5.2 Frozen (< -18°C)
  • 5.3 Deep Cold (< -60°C)

6 Global Cold-Chain Delivery Market, By Component

  • 6.1 Solutions
    • 6.1.1 Refrigeration Equipment
    • 6.1.2 Packaging & Insulation
    • 6.1.3 Monitoring & Control Systems
  • 6.2 Services
    • 6.2.1 Transportation Services
    • 6.2.2 Storage & Warehousing
    • 6.2.3 Installation & Maintenance
    • 6.2.4 Cold Chain Consulting

7 Global Cold-Chain Delivery Market, By Delivery Mode

  • 7.1 Roadways
  • 7.2 Railways
  • 7.3 Airways
  • 7.4 Sea/Waterways
  • 7.5 Multimodal Logistics

8 Global Cold-Chain Delivery Market, By Service Type

  • 8.1 Dedicated Cold Chain
  • 8.2 Shared Cold Chain
  • 8.3 Hybrid Solutions

9 Global Cold-Chain Delivery Market, By Organization Size

  • 9.1 Large Enterprises
  • 9.2 Small & Medium Enterprises (SMEs)

10 Global Cold-Chain Delivery Market, By End User

  • 10.1 Food & Beverages
    • 10.1.1 Fruits & Vegetables
    • 10.1.2 Dairy & Frozen Deserts
    • 10.1.3 Meat, Poultry & Seafood
    • 10.1.4 Bakery & Confectionery
    • 10.1.5 Beverages
  • 10.2 Pharmaceuticals & Biotechnology
    • 10.2.1 Vaccines
    • 10.2.2 Biologics & Blood Products
  • 10.3 Chemicals & Specialty Materials
  • 10.4 Cosmetics & Personal Care
  • 10.5 Other End Users

11 Global Cold-Chain Delivery Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Americold Logistics
  • 14.2 Lineage Logistics
  • 14.3 DHL International GmbH
  • 14.4 United Parcel Service (UPS)
  • 14.5 Maersk
  • 14.6 CEVA Logistics
  • 14.7 Kuehne + Nagel International
  • 14.8 C.H. Robinson Worldwide
  • 14.9 FedEx Corporation
  • 14.10 Nippon Express
  • 14.11 DB Schenker
  • 14.12 XPO Logistics
  • 14.13 AGRO Merchants Group
  • 14.14 NewCold Advanced Cold Logistics
  • 14.15 VersaCold Logistics Services

List of Tables

  • Table 1 Global Cold-Chain Delivery Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Cold-Chain Delivery Market Outlook, By Temperature Type (2023-2034) ($MN)
  • Table 3 Global Cold-Chain Delivery Market Outlook, By Chilled (< 8°C) (2023-2034) ($MN)
  • Table 4 Global Cold-Chain Delivery Market Outlook, By Frozen (< -18°C) (2023-2034) ($MN)
  • Table 5 Global Cold-Chain Delivery Market Outlook, By Deep Cold (< -60°C) (2023-2034) ($MN)
  • Table 6 Global Cold-Chain Delivery Market Outlook, By Component (2023-2034) ($MN)
  • Table 7 Global Cold-Chain Delivery Market Outlook, By Solutions (2023-2034) ($MN)
  • Table 8 Global Cold-Chain Delivery Market Outlook, By Refrigeration Equipment (2023-2034) ($MN)
  • Table 9 Global Cold-Chain Delivery Market Outlook, By Packaging & Insulation (2023-2034) ($MN)
  • Table 10 Global Cold-Chain Delivery Market Outlook, By Monitoring & Control Systems (2023-2034) ($MN)
  • Table 11 Global Cold-Chain Delivery Market Outlook, By Services (2023-2034) ($MN)
  • Table 12 Global Cold-Chain Delivery Market Outlook, By Transportation Services (2023-2034) ($MN)
  • Table 13 Global Cold-Chain Delivery Market Outlook, By Storage & Warehousing (2023-2034) ($MN)
  • Table 14 Global Cold-Chain Delivery Market Outlook, By Installation & Maintenance (2023-2034) ($MN)
  • Table 15 Global Cold-Chain Delivery Market Outlook, By Cold Chain Consulting (2023-2034) ($MN)
  • Table 16 Global Cold-Chain Delivery Market Outlook, By Delivery Mode (2023-2034) ($MN)
  • Table 17 Global Cold-Chain Delivery Market Outlook, By Roadways (2023-2034) ($MN)
  • Table 18 Global Cold-Chain Delivery Market Outlook, By Railways (2023-2034) ($MN)
  • Table 19 Global Cold-Chain Delivery Market Outlook, By Airways (2023-2034) ($MN)
  • Table 20 Global Cold-Chain Delivery Market Outlook, By Sea/Waterways (2023-2034) ($MN)
  • Table 21 Global Cold-Chain Delivery Market Outlook, By Multimodal Logistics (2023-2034) ($MN)
  • Table 22 Global Cold-Chain Delivery Market Outlook, By Service Type (2023-2034) ($MN)
  • Table 23 Global Cold-Chain Delivery Market Outlook, By Dedicated Cold Chain (2023-2034) ($MN)
  • Table 24 Global Cold-Chain Delivery Market Outlook, By Shared Cold Chain (2023-2034) ($MN)
  • Table 25 Global Cold-Chain Delivery Market Outlook, By Hybrid Solutions (2023-2034) ($MN)
  • Table 26 Global Cold-Chain Delivery Market Outlook, By Organization Size (2023-2034) ($MN)
  • Table 27 Global Cold-Chain Delivery Market Outlook, By Large Enterprises (2023-2034) ($MN)
  • Table 28 Global Cold-Chain Delivery Market Outlook, By Small & Medium Enterprises (SMEs) (2023-2034) ($MN)
  • Table 29 Global Cold-Chain Delivery Market Outlook, By End User (2023-2034) ($MN)
  • Table 30 Global Cold-Chain Delivery Market Outlook, By Food & Beverages (2023-2034) ($MN)
  • Table 31 Global Cold-Chain Delivery Market Outlook, By Fruits & Vegetables (2023-2034) ($MN)
  • Table 32 Global Cold-Chain Delivery Market Outlook, By Dairy & Frozen Deserts (2023-2034) ($MN)
  • Table 33 Global Cold-Chain Delivery Market Outlook, By Meat, Poultry & Seafood (2023-2034) ($MN)
  • Table 34 Global Cold-Chain Delivery Market Outlook, By Bakery & Confectionery (2023-2034) ($MN)
  • Table 35 Global Cold-Chain Delivery Market Outlook, By Beverages (2023-2034) ($MN)
  • Table 36 Global Cold-Chain Delivery Market Outlook, By Pharmaceuticals & Biotechnology (2023-2034) ($MN)
  • Table 37 Global Cold-Chain Delivery Market Outlook, By Vaccines (2023-2034) ($MN)
  • Table 38 Global Cold-Chain Delivery Market Outlook, By Biologics & Blood Products (2023-2034) ($MN)
  • Table 39 Global Cold-Chain Delivery Market Outlook, By Chemicals & Specialty Materials (2023-2034) ($MN)
  • Table 40 Global Cold-Chain Delivery Market Outlook, By Cosmetics & Personal Care (2023-2034) ($MN)
  • Table 41 Global Cold-Chain Delivery Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.